Come up with a name for your new list and we'll add to it:
Aspect Biosystems raised a round of funding on May 07, 2018. Investors include
Genome British Columbia.
Aspect Biosystems specializes in 3D bioprinting and tissue engineering. The company's proprietary Lab-on-a-Printer platform technology is enabling advances in understanding fundamental biology, diseas…